InterMune Inc
update Jun 19
9.99
0.14 (+1.42%%)
TODAY
High 10.06
Low 9.73
Open 9.90
Volume 840701
Time Jun 19
52 WEEK SUMMARY
High 12.77
Low 7.21
P/E 0.00
Return
-16.2%
Mkt Cap
815.375 M
InterMune, Inc. is a biotechnology company. The Company's focus is on the research, development and commercialization of therapies in pulmonology and fibrotic diseases. InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor pulmonary and fibrotic diseases.
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=501192545&utmp=%2Fquote%2FITMN%3AUS&utmhn=10.248.67.13&utmac=UA-11413116-12&utmhid=537703764)